abstract |
The present invention provides a method of treating cancer in a mammal comprising administering to the mammal a dendritic cell-mediator, such as CD40L or MDC, and dendritic cells, wherein the dendritic cells can be unmodified or activated, and the dendritic cell-mediator preferably is encoded by a viral vector, such as an adenoviral vector. |